Cargando…
Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery
BACKGROUND: Anti-angiogenic therapy in certain cancers has been associated with improved control of tumor growth and metastasis. Development of anti-angiogenic agents has, however, been saddled with higher attrition rate due to suboptimal efficacy, narrow therapeutic windows, or development of organ...
Autores principales: | Chimote, Geetanjali, Sreenivasan, Jayasree, Pawar, Nilambari, Subramanian, Jyothi, Sivaramakrishnan, Hariharan, Sharma, Somesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145829/ https://www.ncbi.nlm.nih.gov/pubmed/25170251 http://dx.doi.org/10.2147/DDDT.S55621 |
Ejemplares similares
-
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023) -
Clinical trials with anti-angiogenic agents in hematological malignancies
por: Medinger, Michael, et al.
Publicado: (2010) -
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
por: Ciciola, Paola, et al.
Publicado: (2020) -
Vinegar-processed Curcuma phaeocaulis promotes anti-angiogenic activity and reduces toxicity in zebrafish and rat models
por: Liao, Wan, et al.
Publicado: (2021) -
Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017)